Stay updated on Safety of DCC-2618 in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page.

Latest updates to the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page
- Check2 days agoChange DetectedAdded Mastocytosis, Systemic mast cell disease, and Gastrointestinal stromal tumor to the study's conditions list.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check24 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check52 days agoChange Detected- Revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no changes to study details, eligibility criteria, or user-visible content were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedAn in-page glossary control (Show glossary) is added to display definitions. The revision note updates to v3.4.0 with minor wording changes such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'.SummaryDifference0.2%

Stay in the know with updates to Safety of DCC-2618 in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page.